409 related articles for article (PubMed ID: 28411114)
1. Circulating Biologically Active Adrenomedullin (bio-ADM) Predicts Hemodynamic Support Requirement and Mortality During Sepsis.
Caironi P; Latini R; Struck J; Hartmann O; Bergmann A; Maggio G; Cavana M; Tognoni G; Pesenti A; Gattinoni L; Masson S;
Chest; 2017 Aug; 152(2):312-320. PubMed ID: 28411114
[TBL] [Abstract][Full Text] [Related]
2. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
Mebazaa A; Geven C; Hollinger A; Wittebole X; Chousterman BG; Blet A; Gayat E; Hartmann O; Scigalla P; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF;
Crit Care; 2018 Dec; 22(1):354. PubMed ID: 30583748
[TBL] [Abstract][Full Text] [Related]
3. Circulating Biologically Active Adrenomedullin Predicts Organ Failure and Mortality in Sepsis.
Kim H; Hur M; Struck J; Bergmann A; Di Somma S
Ann Lab Med; 2019 Sep; 39(5):454-463. PubMed ID: 31037864
[TBL] [Abstract][Full Text] [Related]
4. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
[TBL] [Abstract][Full Text] [Related]
5. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.
Caironi P; Masson S; Mauri T; Bottazzi B; Leone R; Magnoli M; Barlera S; Mamprin F; Fedele A; Mantovani A; Tognoni G; Pesenti A; Gattinoni L; Latini R;
Eur J Clin Invest; 2017 Jan; 47(1):73-83. PubMed ID: 27864924
[TBL] [Abstract][Full Text] [Related]
6. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: a prospective sequential analysis.
Bayer O; Reinhart K; Kohl M; Kabisch B; Marshall J; Sakr Y; Bauer M; Hartog C; Schwarzkopf D; Riedemann N
Crit Care Med; 2012 Sep; 40(9):2543-51. PubMed ID: 22903091
[TBL] [Abstract][Full Text] [Related]
7. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
[TBL] [Abstract][Full Text] [Related]
8. Association between Initial Fluid Choice and Subsequent In-hospital Mortality during the Resuscitation of Adults with Septic Shock.
Raghunathan K; Bonavia A; Nathanson BH; Beadles CA; Shaw AD; Brookhart MA; Miller TE; Lindenauer PK
Anesthesiology; 2015 Dec; 123(6):1385-93. PubMed ID: 26414499
[TBL] [Abstract][Full Text] [Related]
9. Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial.
Masson S; Caironi P; Fanizza C; Thomae R; Bernasconi R; Noto A; Oggioni R; Pasetti GS; Romero M; Tognoni G; Latini R; Gattinoni L
Intensive Care Med; 2015 Jan; 41(1):12-20. PubMed ID: 25319385
[TBL] [Abstract][Full Text] [Related]
10. Effect of dextran-70 on outcome in severe sepsis; a propensity-score matching study.
Bentzer P; Broman M; Kander T
Scand J Trauma Resusc Emerg Med; 2017 Jul; 25(1):65. PubMed ID: 28683810
[TBL] [Abstract][Full Text] [Related]
11. Fluid resuscitation in severe sepsis and septic shock: albumin, hydroxyethyl starch, gelatin or ringer's lactate-does it really make a difference?
Su F; Wang Z; Cai Y; Rogiers P; Vincent JL
Shock; 2007 May; 27(5):520-6. PubMed ID: 17438457
[TBL] [Abstract][Full Text] [Related]
12. Fluid management in sepsis: The potential beneficial effects of albumin.
Vincent JL; De Backer D; Wiedermann CJ
J Crit Care; 2016 Oct; 35():161-7. PubMed ID: 27481753
[TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock.
Tolppanen H; Rivas-Lasarte M; Lassus J; Sans-Roselló J; Hartmann O; Lindholm M; Arrigo M; Tarvasmäki T; Köber L; Thiele H; Pulkki K; Spinar J; Parissis J; Banaszewski M; Silva-Cardoso J; Carubelli V; Sionis A; Harjola VP; Mebazaa A
Ann Intensive Care; 2017 Dec; 7(1):6. PubMed ID: 28050899
[TBL] [Abstract][Full Text] [Related]
14. Association of Fluid Resuscitation Initiation Within 30 Minutes of Severe Sepsis and Septic Shock Recognition With Reduced Mortality and Length of Stay.
Leisman D; Wie B; Doerfler M; Bianculli A; Ward MF; Akerman M; D'Angelo JK; Zemmel D'Amore JA
Ann Emerg Med; 2016 Sep; 68(3):298-311. PubMed ID: 27085369
[TBL] [Abstract][Full Text] [Related]
15. Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis.
Marino R; Struck J; Maisel AS; Magrini L; Bergmann A; Di Somma S
Crit Care; 2014 Feb; 18(1):R34. PubMed ID: 24533868
[TBL] [Abstract][Full Text] [Related]
16. Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: a randomised controlled pilot study.
van der Voort PH; van Zanten M; Bosman RJ; van Stijn I; Wester JP; van Raalte R; Oudemans-van Straaten HM; Zandstra DF
Eur J Anaesthesiol; 2015 Mar; 32(3):189-98. PubMed ID: 25032942
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Secretoneurin in Patients With Severe Sepsis and Septic Shock: Data From the Albumin Italian Outcome Sepsis Study.
Røsjø H; Masson S; Caironi P; Stridsberg M; Magnoli M; Christensen G; Moise G; Urbano MC; Gattinoni L; Pesenti A; Latini R; Omland T;
Crit Care Med; 2018 May; 46(5):e404-e410. PubMed ID: 29481425
[TBL] [Abstract][Full Text] [Related]
18. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.
Hernández G; Ospina-Tascón GA; Damiani LP; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Granda-Luna V; Cavalcanti AB; Bakker J; ; Hernández G; Ospina-Tascón G; Petri Damiani L; Estenssoro E; Dubin A; Hurtado J; Friedman G; Castro R; Alegría L; Teboul JL; Cecconi M; Cecconi M; Ferri G; Jibaja M; Pairumani R; Fernández P; Barahona D; Cavalcanti AB; Bakker J; Hernández G; Alegría L; Ferri G; Rodriguez N; Holger P; Soto N; Pozo M; Bakker J; Cook D; Vincent JL; Rhodes A; Kavanagh BP; Dellinger P; Rietdijk W; Carpio D; Pavéz N; Henriquez E; Bravo S; Valenzuela ED; Vera M; Dreyse J; Oviedo V; Cid MA; Larroulet M; Petruska E; Sarabia C; Gallardo D; Sanchez JE; González H; Arancibia JM; Muñoz A; Ramirez G; Aravena F; Aquevedo A; Zambrano F; Bozinovic M; Valle F; Ramirez M; Rossel V; Muñoz P; Ceballos C; Esveile C; Carmona C; Candia E; Mendoza D; Sanchez A; Ponce D; Ponce D; Lastra J; Nahuelpán B; Fasce F; Luengo C; Medel N; Cortés C; Campassi L; Rubatto P; Horna N; Furche M; Pendino JC; Bettini L; Lovesio C; González MC; Rodruguez J; Canales H; Caminos F; Galletti C; Minoldo E; Aramburu MJ; Olmos D; Nin N; Tenzi J; Quiroga C; Lacuesta P; Gaudín A; Pais R; Silvestre A; Olivera G; Rieppi G; Berrutti D; Ochoa M; Cobos P; Vintimilla F; Ramirez V; Tobar M; García F; Picoita F; Remache N; Granda V; Paredes F; Barzallo E; Garcés P; Guerrero F; Salazar S; Torres G; Tana C; Calahorrano J; Solis F; Torres P; Herrera L; Ornes A; Peréz V; Delgado G; López A; Espinosa E; Moreira J; Salcedo B; Villacres I; Suing J; Lopez M; Gomez L; Toctaquiza G; Cadena Zapata M; Orazabal MA; Pardo Espejo R; Jimenez J; Calderón A; Paredes G; Barberán JL; Moya T; Atehortua H; Sabogal R; Ortiz G; Lara A; Sanchez F; Hernán Portilla A; Dávila H; Mora JA; Calderón LE; Alvarez I; Escobar E; Bejarano A; Bustamante LA; Aldana JL
JAMA; 2019 Feb; 321(7):654-664. PubMed ID: 30772908
[TBL] [Abstract][Full Text] [Related]
19. What is the Preferred Resuscitation Fluid for Patients with Severe Sepsis and Septic Shock?
Winters ME; Sherwin R; Vilke GM; Wardi G
J Emerg Med; 2017 Dec; 53(6):928-939. PubMed ID: 29079487
[TBL] [Abstract][Full Text] [Related]
20. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database.
Marik PE; Linde-Zwirble WT; Bittner EA; Sahatjian J; Hansell D
Intensive Care Med; 2017 May; 43(5):625-632. PubMed ID: 28130687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
